Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
February-2017 Volume 39 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2017 Volume 39 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review)

  • Authors:
    • Akari Minami
    • Mako Ogino
    • Noriko Nakano
    • Mayuko Ichimura
    • Atsuko Nakanishi
    • Toshiyuki Murai
    • Yasuko Kitagishi
    • Satoru Matsuda
  • View Affiliations / Copyright

    Affiliations: Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan, Department of Food and Nutrition, Faculty of Contemporary Human Life Science, Tezukayama University, Nara 631-8501, Japan, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan
  • Pages: 261-267
    |
    Published online on: January 4, 2017
       https://doi.org/10.3892/ijmm.2017.2847
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoporosis is a bone disease that poses a tremendous burden to health care. The receptor activator of nuclear factor-κB (RANK) and its ligand (RANKL) have been a major focus of this research field. RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also adjusts bone homeostasis both in normal physiology and in bone disease. Consequently, novel drugs specifically targeting RANK-RANKL and their signaling pathways in osteoclasts are expected to revolutionize the treatment of various bone diseases such as osteoporosis. Osteoclasts are the exclusive cells involved in bone resorption. Abnormal activation of osteoclasts can lead to reduced bone density, resulting in osteopenia, osteoporosis and other bone disorders. To date, the mechanism of how osteoclast precursors differentiate into mature osteoclasts remains elusive. Cell proliferation and cell death may be key processes in the progression as well as other cell types. Oncogene products and tumor-suppressor molecules play a pivotal role in regulating the processes, which are important in regulating the configuration of bone disorders. Based on the understanding of these processes, promising alternatives to the use of medications against osteoporosis include specific diets with plant-derived supplements to modulate the expression and/or activity of these molecules. In this review, we summarize the progress of research with a focus on the modulatory roles of oncogene products and tumor-suppressor molecules and suggest the scope of further research concerning the prevention of osteoporosis in this field.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Ward LM, Konji VN and Ma J: The management of osteoporosis in children. Osteoporos Int. 27:2147–2179. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Pi C, Li YP, Zhou X and Gao B: The expression and function of microRNAs in bone homeostasis. Front Biosci (Landmark Ed). 20:119–138. 2015. View Article : Google Scholar

3 

Horwood NJ: Macrophage polarization and bone formation: a review. Clin Rev Allergy Immunol. 51:79–86. 2016. View Article : Google Scholar

4 

Sartori R and Sandri M: BMPs and the muscle-bone connection. Bone. 80:37–42. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Paul S, Lee JC and Yeh LC: A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Growth Factors. 27:121–131. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Riggs BL, Khosla S and Melton LJ III: Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 23:279–302. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Murphy CM, Schindeler A, Gleeson JP, Yu NY, Cantrill LC, Mikulec K, Peacock L, O'Brien FJ and Little DG: A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acta Biomater. 10:2250–2258. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Papapetrou PD: Bisphosphonate-associated adverse events. Hormones (Athens). 8:96–110. 2009. View Article : Google Scholar

9 

Mandal CC, Ghosh-Choudhury G and Ghosh-Choudhury N: Phosphatidylinositol 3 kinase/Akt signal relay cooperates with Smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology. 150:4989–4998. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Lampiasi N, Russo R and Zito F: The alternative faces of macrophage generate osteoclasts. BioMed Res Int. 2016:90896102016. View Article : Google Scholar : PubMed/NCBI

11 

Mandal CC, Das F, Ganapathy S, Harris SE, Choudhury GG and Ghosh-Choudhury N: Bone morphogenetic protein-2 (BMP-2) activates NFATc1 transcription factor via an autoregulatory loop involving Smad/Akt/Ca2+ signaling. J Biol Chem. 291:1148–1161. 2016. View Article : Google Scholar

12 

Li W, Liu Z, Zhao C and Zhai L: Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer. Oncol Rep. 34:1345–1352. 2015.PubMed/NCBI

13 

Aguirre E, Renner O, Narlik-Grassow M and Blanco-Aparicio C: Genetic modeling of PIM proteins in cancer: proviral tagging and cooperation with oncogenes, tumor suppressor genes, and carcinogens. Front Oncol. 4:1092014. View Article : Google Scholar : PubMed/NCBI

14 

Yu XM and Salter MW: Src, a molecular switch governing gain control of synaptic transmission mediated by N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA. 96:7697–7704. 1999. View Article : Google Scholar : PubMed/NCBI

15 

Ingraham CA, Cox ME, Ward DC, Fults DW and Maness PF: c-Src and other proto-oncogenes implicated in neuronal differentiation. Mol Chem Neuropathol. 10:1–14. 1989. View Article : Google Scholar : PubMed/NCBI

16 

Reichmann E: Oncogenes and epithelial cell transformation. Semin Cancer Biol. 5:157–165. 1994.PubMed/NCBI

17 

Kramer JL, Baltathakis I, Alcantara OS and Boldt DH: Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br J Haematol. 117:727–734. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Grabliauskaite K, Hehl AB, Seleznik GM, Saponara E, Schlesinger K, Zuellig RA, Dittmann A, Bain M, Reding T, Sonda S, et al: p21WAF1/Cip1 limits senescence and acinar-to-ductal metaplasia formation during pancreatitis. J Pathol. 235:502–514. 2015. View Article : Google Scholar

19 

Nakanishi A, Wada Y, Kitagishi Y and Matsuda S: Link between PI3K/AKT/PTEN pathway and NOX proteinin diseases. Aging Dis. 5:203–211. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Matsuda S, Nakanishi A, Minami A, Wada Y and Kitagishi Y: Functions and characteristics of PINK1 and Parkin in cancer. Front Biosci (Landmark Ed). 20:491–501. 2015. View Article : Google Scholar

21 

Günzl P and Schabbauer G: Recent advances in the genetic analysis of PTEN and PI3K innate immune properties. Immunobiology. 213:759–765. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Appelman-Dijkstra NM and Papapoulos SE: Modulating bone resorption and bone formation in opposite directions in the treatment of postmenopausal osteoporosis. Drugs. 75:1049–1058. 2015. View Article : Google Scholar : PubMed/NCBI

23 

An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L and Chen B: Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci. 147:46–58. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Wagner EF and Eferl R: Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 208:126–140. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Asagiri M and Takayanagi H: The molecular understanding of osteoclast differentiation. Bone. 40:251–264. 2007. View Article : Google Scholar

26 

Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB and Oh J: GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol. 183:3390–3399. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Takayanagi H: The role of NFAT in osteoclast formation. Ann NY Acad Sci. 1116:227–237. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Macián F, López-Rodríguez C and Rao A: Partners in transcription: NFAT and AP-1. Oncogene. 20:2476–2489. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Zeng XZ, He LG, Wang S, Wang K, Zhang YY, Tao L, Li XJ and Liu SW: Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Acta Pharmacol Sin. 37:255–263. 2016. View Article : Google Scholar

30 

Lee EJ, Kim JL, Gong JH, Park SH and Kang YH: Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway. Biomed Res Int. 2015:6801452015.

31 

Fukunaga T, Zou W, Warren JT and Teitelbaum SL: Vinculin regulates osteoclast function. J Biol Chem. 289:13554–13564. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Shakespeare W, Yang M, Bohacek R, Cerasoli F, Stebbins K, Sundaramoorthi R, Azimioara M, Vu C, Pradeepan S, Metcalf C III, et al: Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. Proc Natl Acad Sci USA. 97:9373–9378. 2000. View Article : Google Scholar : PubMed/NCBI

33 

Rucci N, Ricevuto E, Ficorella C, Longo M, Perez M, Di Giacinto C, Funari A, Teti A and Migliaccio S: In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells. Bone. 34:697–709. 2004. View Article : Google Scholar : PubMed/NCBI

34 

Recchia I, Rucci N, Funari A, Migliaccio S, Taranta A, Longo M, Kneissel M, Susa M, Fabbro D and Teti A: Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway Bone. 34:65–79. 2004.

35 

Battaglino R, Kim D, Fu J, Vaage B, Fu XY and Stashenko P: c-Myc is required for osteoclast differentiation. J Bone Miner Res. 17:763–773. 2002. View Article : Google Scholar : PubMed/NCBI

36 

Daumer KM, Taparowsky EJ, Hall DJ and Steinbeck MJ: Transcription from the tartrate-resistant acid phosphatase promoter is negatively regulated by the Myc oncoprotein. J Bone Miner Res. 17:1701–1709. 2002. View Article : Google Scholar : PubMed/NCBI

37 

Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, Zimmermann B, Aspalter IM, Franco CA, Boettger T, et al: FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 529:216–220. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Adapala NS, Barbe MF, Tsygankov AY, Lorenzo JA and Sanjay A: Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b. J Cell Biochem. 115:1277–1289. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Rubin J, Murphy TC, Rahnert J, Song H, Nanes MS, Greenfield EM, Jo H and Fan X: Mechanical inhibition of RANKL expression is regulated by H-Ras-GTPase. J Biol Chem. 281:1412–1418. 2006. View Article : Google Scholar

40 

Sharma R, Wu X, Rhodes SD, Chen S, He Y, Yuan J, Li J, Yang X, Li X, Jiang L, et al: Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Hum Mol Genet. 22:4818–4828. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Zauli G, Rimondi E, Corallini F, Fadda R, Capitani S and Secchiero P: MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway. J Bone Miner Res. 22:1621–1630. 2007. View Article : Google Scholar : PubMed/NCBI

42 

Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, et al: p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol. 172:115–125. 2006. View Article : Google Scholar

43 

Zambetti GP, Horwitz EM and Schipani E: Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development. J Cell Biol. 172:795–797. 2006. View Article : Google Scholar : PubMed/NCBI

44 

Zhang J, Lazarenko OP, Blackburn ML, Badger TM, Ronis MJ and Chen JR: Blueberry consumption prevents loss of collagen in bone matrix and inhibits senescence pathways in osteoblastic cells. Age (Dordr). 35:807–820. 2013. View Article : Google Scholar

45 

Li Y and Tollefsbol TO: p16(INK4a) suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms. PLoS One. 6:e174212011. View Article : Google Scholar : PubMed/NCBI

46 

Campisi J and d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Wang X, Huang H and Young KH: The PTEN tumor suppressor gene and its role in lymphoma pathogenesis. Aging (Albany NY). 7:1032–1049. 2015. View Article : Google Scholar

48 

Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, et al: Micro-RNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar

49 

Blüml S, Friedrich M, Lohmeyer T, Sahin E, Saferding V, Brunner J, Puchner A, Mandl P, Niederreiter B, Smolen JS, et al: Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells. Ann Rheum Dis. 74:227–233. 2015. View Article : Google Scholar

50 

Jang HD, Noh JY, Shin JH, Lin JJ and Lee SY: PTEN regulation by the Akt/GSK-3β axis during RANKL signaling. Bone. 55:126–131. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Sugatani T, Alvarez U and Hruska KA: PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem. 278:5001–5008. 2003. View Article : Google Scholar

52 

Hu G, Han C and Chen J: Inhibition of oncogene expression by green tea and (−)-epigallocatechin gallate in mice. Nutr Cancer. 24:203–209. 1995. View Article : Google Scholar

53 

Prasad KN, Kumar A, Kochupillai V and Cole WC: High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr. 18:13–25. 1999. View Article : Google Scholar : PubMed/NCBI

54 

Xie L, Jiang Y, Ouyang P, Chen J, Doan H, Herndon B, Sylvester JE, Zhang K, Molteni A, Reichle M, et al: Effects of dietary calorie restriction or exercise on the PI3K and Ras signaling pathways in the skin of mice. J Biol Chem. 282:28025–28035. 2007. View Article : Google Scholar : PubMed/NCBI

55 

Huang L, Bi HC, Liu YH, Wang YT, Xue XP and Huang M: CAR-mediated up-regulation of CYP3A4 expression in LS174T cells by Chinese herbal compounds. Drug Metab Pharmacokinet. 26:331–340. 2011. View Article : Google Scholar : PubMed/NCBI

56 

Yeon JT, Kim KJ, Choi SW, Moon SH, Park YS, Ryu BJ, Oh J, Kim MS, Erkhembaatar M, Son YJ, et al: Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation. PLoS One. 9:e889742014. View Article : Google Scholar

57 

Hasegawa S, Yonezawa T, Ahn JY, Cha BY, Teruya T, Takami M, Yagasaki K, Nagai K and Woo JT: Honokiol inhibits osteoclast differentiation and function in vitro. Biol Pharm Bull. 33:487–492. 2010. View Article : Google Scholar : PubMed/NCBI

58 

Li J, Shao X, Wu L, Feng T, Jin C, Fang M, Wu N and Yao H: Honokiol: an effective inhibitor of tumor necrosis factor-α-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts. Acta Biochim Biophys Sin (Shanghai). 43:380–386. 2011. View Article : Google Scholar

59 

Hahm ER, Singh KB and Singh SV: c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle. 15:2309–2320. 2016. View Article : Google Scholar : PubMed/NCBI

60 

Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K and Eucker J: Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol. 591:43–51. 2008. View Article : Google Scholar : PubMed/NCBI

61 

Zhang J, Lazarenko OP, Blackburn ML, Shankar K, Badger TM, Ronis MJ and Chen JR: Feeding blueberry diets in early life prevent senescence of osteoblasts and bone loss in ovariectomized adult female rats. PLoS One. 6:e244862011. View Article : Google Scholar : PubMed/NCBI

62 

Liu W, Lu X, He G, Gao X, Li M, Wu J, Li Z, Wu J, Wang J and Luo C: Cytosolic protection against ultraviolet induced DNA damage by blueberry anthocyanins and anthocyanidins in hepatocarcinoma HepG2 cells. Biotechnol Lett. 35:491–498. 2013. View Article : Google Scholar

63 

Vetterli L, Brun T, Giovannoni L, Bosco D and Maechler P: Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. J Biol Chem. 286:6049–6060. 2011. View Article : Google Scholar

64 

Martí-Centelles R, Falomir E, Murga J, Carda M and Marco JA: Inhibitory effect of cytotoxic stilbenes related to resveratrol on the expression of the VEGF, hTERT and c-Myc genes. Eur J Med Chem. 103:488–496. 2015. View Article : Google Scholar : PubMed/NCBI

65 

Wang X, Wang D and Zhao Y: Effect and mechanism of resveratrol on the apoptosis of lung adenocarcinoma cell line A549. Cell Biochem Biophys. 73:527–531. 2015. View Article : Google Scholar

66 

Lee SJ, Park K, Ha SD, Kim WJ and Moon SK: Gleditsia sinensis thorn extract inhibits human colon cancer cells: the role of ERK1/2, G2/M-phase cell cycle arrest and p53 expression. Phytother Res. 24:1870–1876. 2010. View Article : Google Scholar : PubMed/NCBI

67 

Lee SJ, Ryu DH, Jang LC, Cho SC, Kim WJ and Moon SK: Suppressive effects of an ethanol extract of Gleditsia sinensis thorns on human SNU-5 gastric cancer cells. Oncol Rep. 29:1609–1616. 2013.PubMed/NCBI

68 

Lu Y, Li CS and Dong Q: Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res. 27:312008. View Article : Google Scholar : PubMed/NCBI

69 

Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS and Du W: Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 301:185–192. 2011. View Article : Google Scholar : PubMed/NCBI

70 

Gali-Muhtasib H, Kuester D, Mawrin C, Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C, Schoenfeld P, Peters B, et al: Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res. 68:5609–5618. 2008. View Article : Google Scholar : PubMed/NCBI

71 

Ichwan SJ, Al-Ani IM, Bilal HG, Suriyah WH, Taher M and Ikeda MA: Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines. Chin J Physiol. 57:249–255. 2014. View Article : Google Scholar : PubMed/NCBI

72 

Lee SJ, Kim HM, Cho YH, Park K, Kim EJ, Jung KH, Kim CH, Kim WJ and Moon SK: Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase. Oncol Rep. 18:729–736. 2007.PubMed/NCBI

73 

Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ, Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262. 2010. View Article : Google Scholar : PubMed/NCBI

74 

Zhang L, Pu Z and Wang J, Zhang Z, Hu D and Wang J: Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway. Int J Mol Sci. 15:8153–8168. 2014. View Article : Google Scholar : PubMed/NCBI

75 

Byambaragchaa M, Dela Cruz J, Kh A and Hwang SG: Anticancer potential of an ethanol extract of Saussurea involucrata against hepatic cancer cells in vitro. Asian Pac J Cancer Prev. 15:7527–7532. 2014. View Article : Google Scholar : PubMed/NCBI

76 

Liu J, Shen M, Yue Z, Yang Z, Wang M, Li C, Xin C, Wang Y, Mei Q and Wang Z: Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine. 19:756–762. 2012. View Article : Google Scholar : PubMed/NCBI

77 

Liu TE, Zhang L, Wang S, Chen C and Zheng J: Tripterygium glycosides induce premature ovarian failure in rats by promoting p53 phosphorylation and activating the serine/threonine kinase 11-p53-p21 signaling pathway. Exp Ther Med. 10:12–18. 2015.PubMed/NCBI

78 

Wong TF, Takeda T, Li B, Tsuiji K, Kitamura M, Kondo A and Yaegashi N: Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecol Oncol. 122:141–148. 2011. View Article : Google Scholar : PubMed/NCBI

79 

Yoshida H, Okumura N, Kitagishi Y, Nishimura Y and Matsuda S: Ethanol extract of Rosemary repressed PTEN expression in K562 culture cells. Int J Appl Biol Pharm Technol. 2:316–322. 2011.

80 

Wang X, He H, Lu Y, Ren W, Teng KY, Chiang CL, Yang Z, Yu B, Hsu S, Jacob ST, et al: Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Biochim Biophys Acta. 1853:244–253. 2015. View Article : Google Scholar :

81 

Royston KJ and Tollefsbol TO: The epigenetic impact of cruciferous vegetables on cancer prevention. Curr Pharmacol Rep. 1:46–51. 2015. View Article : Google Scholar : PubMed/NCBI

82 

Eason RR, Velarde MC, Chatman L Jr, Till SR, Geng Y, Ferguson M, Badger TM and Simmen RC: Dietary exposure to whey proteins alters rat mammary gland proliferation, apoptosis, and gene expression during postnatal development. J Nutr. 134:3370–3377. 2004.PubMed/NCBI

83 

Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG and Ghosh-Choudhury N: Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat. 118:213–228. 2009. View Article : Google Scholar

84 

Ishii H, Horie Y, Ohshima S, Anezaki Y, Kinoshita N, Dohmen T, Kataoka E, Sato W, Goto T, Sasaki J, et al: Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice. J Hepatol. 50:562–571. 2009. View Article : Google Scholar : PubMed/NCBI

85 

Rovito D, Giordano C, Vizza D, Plastina P, Barone I, Casaburi I, Lanzino M, De Amicis F, Sisci D, Mauro L, et al: Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells. J Cell Physiol. 228:1314–1322. 2013. View Article : Google Scholar

86 

Kitagishi Y and Matsuda S: Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury. Alzheimers Res Ther. 5:422013. View Article : Google Scholar : PubMed/NCBI

87 

Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ and Peters JM: Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal. 19:1163–1171. 2007. View Article : Google Scholar : PubMed/NCBI

88 

Mohapatra P, Satapathy SR, Siddharth S, Das D, Nayak A and Kundu CN: Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. Int J Biochem Cell Biol. 66:75–84. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Minami A, Ogino M, Nakano N, Ichimura M, Nakanishi A, Murai T, Kitagishi Y and Matsuda S: Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review). Int J Mol Med 39: 261-267, 2017.
APA
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T. ... Matsuda, S. (2017). Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review). International Journal of Molecular Medicine, 39, 261-267. https://doi.org/10.3892/ijmm.2017.2847
MLA
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T., Kitagishi, Y., Matsuda, S."Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review)". International Journal of Molecular Medicine 39.2 (2017): 261-267.
Chicago
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T., Kitagishi, Y., Matsuda, S."Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review)". International Journal of Molecular Medicine 39, no. 2 (2017): 261-267. https://doi.org/10.3892/ijmm.2017.2847
Copy and paste a formatted citation
x
Spandidos Publications style
Minami A, Ogino M, Nakano N, Ichimura M, Nakanishi A, Murai T, Kitagishi Y and Matsuda S: Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review). Int J Mol Med 39: 261-267, 2017.
APA
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T. ... Matsuda, S. (2017). Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review). International Journal of Molecular Medicine, 39, 261-267. https://doi.org/10.3892/ijmm.2017.2847
MLA
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T., Kitagishi, Y., Matsuda, S."Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review)". International Journal of Molecular Medicine 39.2 (2017): 261-267.
Chicago
Minami, A., Ogino, M., Nakano, N., Ichimura, M., Nakanishi, A., Murai, T., Kitagishi, Y., Matsuda, S."Roles of oncogenes and tumor-suppressor genes in osteoclastogenesis (Review)". International Journal of Molecular Medicine 39, no. 2 (2017): 261-267. https://doi.org/10.3892/ijmm.2017.2847
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team